ENDRA Life Sciences- Warrants (12/05/2022) Other Current Assets

The latest other current assets for NDRAW is $180K as of March 2026. That compares with $120K in the prior-year period — up 56.2% year over year. Investors often review this figure alongside ENDRA Life Sciences- Warrants (12/05/2022)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NDRAW's other current assets moved from $120K to $180K — a 56.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ENDRA Life Sciences- Warrants (12/05/2022)'s operating scale or balance-sheet position.

A other current assets figure of $180K for NDRAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NDRAW's other current assets ($180K), review year-over-year change from $120K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack ENDRA Life Sciences- Warrants (12/05/2022)'s other current assets against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.